Drug profile · INN
covid-19 vaccine (ad26.cov2-s [recombinant])
JCOVDEN (PREVIOUSLY COVID-19 VACCINE JANSSEN)
- Patents linked
- 0
- News articles
- 0
Quick answer
covid-19 vaccine (ad26.cov2-s [recombinant]) (JCOVDEN (PREVIOUSLY COVID-19 VACCINE JANSSEN)) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN covid-19 vaccine (ad26.cov2-s [recombinant])
Brand JCOVDEN (PREVIOUSLY COVID-19 VACCINE JANSSEN)
ATC code J07BN02
Frequently asked questions
What is covid-19 vaccine (ad26.cov2-s [recombinant])?
covid-19 vaccine (ad26.cov2-s [recombinant]) (JCOVDEN (PREVIOUSLY COVID-19 VACCINE JANSSEN)) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for covid-19 vaccine (ad26.cov2-s [recombinant])?
JCOVDEN (PREVIOUSLY COVID-19 VACCINE JANSSEN) is a marketed brand name for covid-19 vaccine (ad26.cov2-s [recombinant]). Check FDA Drugs@FDA for the current US label holder and prescribing information.